Brown & Brown (BRO) recently drew investor attention after a period of mixed returns, including a decline of 10.65% year to date. This has prompted closer scrutiny of its valuation and business fundamentals.
See our latest analysis for Brown & Brown.
Despite the year to date share price decline of 10.65% and a 1 year total shareholder return that is down 32.62%, Brown & Brown has recently seen momentum firming, with a 30 day share price return of 17.46% and a 7 day gain of 2.50% from a latest close of US$69.35.
If Brown & Brown's recent swings have you reconsidering your watchlist, this could be a good moment to broaden your search and uncover 18 top founder-led companies
After a sharp rebound off this year’s lows, Brown & Brown’s recent rally has narrowed the gap to analyst price targets but still sits at what one model suggests is a sizeable intrinsic discount, so does the risk reward still lean toward buyers or caution from here?
Against Brown & Brown's last close of $69.35, the most followed narrative anchors on a fair value of $73.38, built from detailed long term forecasts.
Strong cash flow from operations, combined with a strategic focus on leveraging a diversified portfolio across geographies and lines of business, positions the company to navigate economic uncertainties and potentially increase future earnings stability and growth.
Want to see what is driving that fair value gap for Brown & Brown? The story ties together acquisition led scale, margin pressure, and a richer future earnings multiple. The key assumptions sit in the earnings path and how the market might price those profits. The full narrative spells out the exact mix.
Result: Fair Value of $73.38 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Brown & Brown's narrative still faces real tests, including pressure on profit margins and potential revenue headwinds from tariffs, inflation, and shifting insurance legislation.
Find out about the key risks to this Brown & Brown narrative.
The narrative around Brown & Brown leans on a fair value of $73.38, yet the company currently trades on a P/E of 20.7x compared with a US Insurance industry average of 12.3x and a peer average of 31.7x. Our fair ratio estimate of 12.9x hints at meaningful valuation risk if sentiment cools.
To see how these valuation gaps line up with the underlying numbers and what the market could move toward over time, take a closer look at our breakdown, starting with See what the numbers say about this price — find out in our valuation breakdown.
Does the mixed sentiment around Brown & Brown leave you unsure which way to lean? Take a closer look at the balance of 3 key rewards and 1 important warning sign
If Brown & Brown has you rethinking your portfolio, do not stop here. Use the screener to uncover fresh opportunities that might better fit your goals.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com